Search results
Maine woman files class-action lawsuit against Cigna for denying coverage of weight-loss medication
Portland Press Herald, Maine via Yahoo News· 11 hours agoJun. 4—A Yarmouth woman has filed a federal class-action lawsuit against Cigna Health and Life Insurance Co. for denying coverage of a weight loss drug ...
Patient perspective points way to affordable meds
The Daily Sentinel· 3 days agoWhenever state policy makers trumpet efforts to reduce prescription drug costs, anxieties among patients across Colorado tend to rise. Months into the work ...
Bipartisan Efforts To Legislate Pharmaceutical Patent Reform Heat Up
Forbes· 2 days agoToday, multiple bipartisan bills have been introduced that seek to rein in different ways that drug...
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are...
The Grass Valley Union· 4 days agoData were reported from 173 patients with advanced ROS1-positive non-small cell lung cancer (NSCLC) who were treated with taletrectinib.
Memphis mother's #DoItforShelby campaign highlights opioid crisis, son's addiction death
The Commercial Appeal via Yahoo News· 1 day agoOnce approved, it is vital that all patients have access to these safer treatments. As a Tennessean,...
Studies question hospital operations on tax breaks, service to poor and underinsured
Gannett via AOL· 2 days ago“With Medicaid expansion due to the Affordable Care Act, if there is more government support for the...
...Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced...
Char-Koosta News· 4 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
'They can't afford the cost': Cincinnati mom joins Ohio lawmaker in campaign for affordable insulin
WCPO Cincinnati· 7 days agoSeven years after burying her first-born daughter, Antoinette Worsham still grieves. The 22-year-old died in 2017, the day before her younger sister's birthday, Worsham said. Antavia's insulin ...
Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible ...
KOLR - KSFX Ozarks· 4 days agoBoehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company's inhalers is now available. With this program,
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoInnovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO, U.S. and SUZHOU, China